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Considering the data and including two patients of the authors, there exist only 18 authentic cases of
primary malignant melanoma ofthe lower respiratory tract and/or the lung. The tumor was localized
in the endobronchial space in 7 cases and only once in the trachea. Endobronchial localization, to-
gether with the involvement of the surrounding lung tissue, was found in two cases, whereas in 8 pa-
tients, the tumor was found exclusively in the lung parenchyma. Successful resection could be
performed in 14 of the 18 cases. Survival was influenced primarily by operability, and on actual size
and extension. The authors question the role of the obduction in the diagnostic criteria, because most
of the survivors, even up to ten years postsurgery were considered primary. Apart from the various
imaging methods, diagnostic endoscopy (i.e., bronchoscopy) and the histology of the biopsy mater-
ial are major aides in the diagnosis of primary character, location, and operability, as well as in the
elaboration of the surgical plans, than it is usual in cases of other tumors.
KEY WORDS: melanoma malignum, primary melanoma in lung, primary melanoma in the
bronchial tract
INTRODUCTION
Eighty-eightpercent oftheprimary malignantmelanomas
appear in the skin or the eye (1). As primary tumors,
melanomas occur considerably less frequently in the oral
cavity, upper respiratory tract, esophagus, liver, gall blad-
der, ovaries, cervix uteri, uterus, urogenital system, and
leptomeninx. The malignant melanoma usually occurs as
a metastatic tumor in the lower respiratory tract and/or
lung (in 7% to 9% of those ofcutaneous origin and in 2%
of the autopsies) (2,3), and the primary forms of the same
localization are extremely rare. It is assumed that the pri-
mary melanomas derive from the benign melanocytes
moving together with the mesoderm and/or entoderm
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(4,5). Similar cells have been isolated from the mucosa of
the esophagus and larynx. The latter organs derive from
the 6th branchial arch as parts of the pulmonal system.
Nevertheless, the presence ofeven benign melanocytes in
the bronchopulmonary system is not usual (6). According
tosome suggestions, melanocyticmetaplasy alsomay take
place under various stimuli in epithelial cells, salivary
glands, and nervous structures (7). It is possible also that
some precursor cells (e.g., Kultschitsky cells) may un-
dergo both neuroendocrine and melanocytic differentia-
tion (8,9,15).
A careful analysis of the literature reveals that the ma-
jority of the really primary malignant melanomas located
in the lower respiratory tract and/or lung have been de-
scribed in English-speaking countries (Table 1); we find
only Danish (11), French (12), and Spanish (13) publica-
tions in Europe, in addition to those in Great Britain
(5,13a-21). Thus, we describe observations obtained from
ourtwo patients and survey the relativelyfew publications.170 P. BARZO et al.
CASE REPORTS
Mrs. B. J. is a 43-year-old patient. In her anamnesis there
was a uterus exstirpation because ofmyomas. She recov-
ered in our department on November 3, 1989, because of
shadow seen by X-ray examination in the left thoracal re-
gion. She has been coughing for several weeks and is oc-
casionally febrilic. Physical examination did not reveal
any alterations on the skin; no lymph nodes could be
found. The repeated posteroanteriorsummation X-ray ex-
amination and tomographic imaging of the left side in
planes of sagittal direction revealed a round vascular
shadow about 6 to 7 cm in the left hilar region (Figure 1).
Bronchoscopy revealed the presence ofa tumor at the be-
ginning of the left upper lobe bronchus; the tumor was
about 8 mm with a slightly uneven surface and brown-
gray color (Figure 2). Histologic and cytologic analyses
of the excised sample suggested that the alteration repre-
sented an anaplastic cancer of the lung consisting of in-
termediary cells. Because of this diagnosis, left pul-
monectomy was performed on November 22, 1989.
Pathologic, histologicandmacroscopic findingswere left
lung, 18 x 12 x 3 cm weighing 290 g. In one ofthe branches
of the upper lobe bronchus we found a brown-gray tumor
about 8mm. The bronchial wall infiltratedby thetumorwas
in close proximity to a huge lymphnode of the hilus; this
node was 5 x4x 3.5 cm, oftumorous appearance, part gray-
white, part dark brown-gray, and soft and fragile.
Microscopic examination showed the tumor infiltrating
all layers of the cartilagineous wall of the bronchus, and
intruding into the bronchial lumen in polyplike form. The
tumor surface is covered in part by typical ciliated respi-
ratory epithelium, displaying in some places slightly atyp-
ical planocellular metaplasy or atypical melanocytic
hyperplasy. Under the epithelium, several naevoid cell
groups that were confluent with the tumorwere observed.
Table I Basic data of case reports recognizable as primary malignant melanoma of the lower respiratory tract and/or lung
Authors No Year Age Sex
Searchfor
Survival primary
Country time melanoma
Salm 1963
Reed and Kent 2 1964
Reid and Mehta 3 1966
Jensen and Egedorf 5 1967
Allen and Drash 6 1968
Taboada et al. 7 1972
8 1972
45 M England 6 months
Localization: left lower lobe bronchus, left upper lobe
Diagnosis from: bronchoscopic biopsy, surgical biopsy, autopsy
Operation: pneumonectomy
71 M USA
Localization: left lower lobe
Diagnosis from: surgical biopsy
Operation: lobectomy
10 years
60 F New Zealand
Localization: right lower lobe bronchus
Diagnosis from: surgical biopsy
Operation: pneumonectomy
11 years
35 M USA
Localization: trachea lower third
Diagnosis from: surgical biopsy
Operation: trachearesection + plastica
postoperative
death
61 F Denmark
Localization: left upper lobe
Diagnosis from: surgical biopsy
Operation: segmental resection
7 months
40 F USA
Localization: right lower lobe
Diagnosis from: surgical biopsy
Operation: lobectomy
not published
56 M USA
Localization: left lower lobe
Diagnosis from: surgical biopsy, autopsy
Operation: lobectomy
year
40 M USA
Localization: left upper lobe
Diagnosis from: surgical biopsy
Operation: pneumonectomy
3 years
done
done
done
done
done
done
done
doneCLINICAL SIGNIFICANCE OF THE PRIMARY MALIGNANTMELANOMA 171
Table I Continued
Authors No Year Age Sex Country
Survival
time
Searchfor
primary
melanoma
Walter et al. 9 1972
Adebonojo et al. 10 1979
Gephardt 11 1981
Cagle et al. 12 1983
Alghanem et al. 13 1987
Santos et al. 14 1987
Bagwell et al. 15 1989
Jennings et al. 16 1990
33 M France
Localization: left lung, pleura
Diagnosis from: thoractomical biopsy, autopsy
Operation: explorative thoracotomy
22 months
55 F Nigeria 3 years
Localization: fight upper lobe bronchus
Diagnosis from: bronchoscopic biopsy, surgical biopsy
Operation: pneumonectomy
47 M USA
Localization: fight upper main bronchus
Diagnosis from: autopsy
Operation: no
before interv.
80 M USA 5.5 months
Localization: the space between fight central and lower lobes
Diagnosis from: thoraeotomic biopsy, autopsy
Operation: explorative thoracotomy
42 F USA
Localization: left lower lobe
Diagnosis from: surgical biopsy
Operation: lobectomy
done
58 M Spain
Localization: right lower lobe bronchus
Diagnosis from: surgical biopsy
Operation: lobectomy
done
62 M USA
Localization: left upper lobe bronchus
Diagnosis from: surgical biopsy
Operation: lobectomy
done
34 F USA
Localization: lingula bronchus
Diagnosis from: bronchoscopical biopsy
Operation: pneumonectomy
done
2.5 years done
18 months done
2 months done
19 months done
Several small exulcerations also were found on the tumor
surface. Most ofthe tumor mass consisted ofspindle cells
with hyperchromic nuclei; the cells were partly ordered
in bundles ofvarious directions or in vortexlike structures
(Figure 3). Although the tumor was rich in cells, the oc-
currence of apparent mitoses was not high. The massive
brown pigment depositions of the tumor cells proved to
be melanin with silver stains; the distribution of this pig-
ment is not uniform (Figure 4). The histologic structure
ofthelymphnode is unrecognizable; it is filledcompletely
with tumor tissue. Similar to other bronchial tumors in all
aspects, the tumor is in part fusocellular in structure con-
taining abundantly melanin pigment, and in part large,
pale rounded or polygonal cellular in structure with large,
vacuolatednucleiandmostlyballonizedcytoplasm. These
latter cells contain much less melanin. The HMB-45
melanoma marker procedure proved to be positive. The
resection line ofthe leftmain bronchus did not contain tu-
morous tissue.
Diagnosis: Melanoma malignum bronchi lobi superi-
oris pulmonis sinistri. Metastasis tumoris in lymphonodo
hili pulmonis sinistri.
Opinion: The tumor is considered a primary bronchial
melanoma. This opinion is supported by the following
morphologic signs: a single tumor of central location in
the bronchial lumen; the polypoid surface of the tumor
coveredby an epithelium displaying atypical melanocytic
proliferationand atypical planocellularmetaplasy, andep-
ithelium naevoid cell nests confluent with the tumor
(Figures 3--4).
The postoperative period was without complication.
The patient received Deticen (dacarbasin) therapy in 12
cycles during the first postoperative year.
The metastatic origin of this tumor in the bronchus of
the left upper lobe of lung could be excluded with high
probability based on the negative results of dermatologic,
otorhinolaryngologic, oculistic, and gynecologic, and ab-
dominal ultrasound examinations. Because the skin did172 P. BARZO et al.
Figure 1 Chest X-ray of pa direction. In the left hilar region one can
see a round shadow of about 6-8 cm.
Figure 2 A tumor of about 6-8 mm can be seen in the lumen of the
bronchus of the left upper lobe.
Figure 3 Spindle cells with hyperchromic nuclei, ordered partly in
bundles, partly in vortexes x 100, hematoxylin-eosin staining.
Figure 4 Massive brown pigment in the tumor cells with uneven
distribution x 160, silver staining.
not show any alteration, excision from the skin was not
performed. Currently, the patient suffers only from an ef-
fort dyspnoe and otherwise is without complaint. She
gained about 10 kg body weight. Urine analyses using
Thormilen and Jaksch tests for melanin proved negative.
Mrs. K. L., age 81 years complainedofdiffuse chest pains
and dyspnoe. X-ray examination showed an egg-sized
shadow in the segment 10 of the left side and a lymph node
conglomerate in the hilus (Figure 5). Bronchoscopywas per-
formed on November 21, 1990 and revealed that the lower
part ofthe leftmain bronchus was almost completely closed
by a tumorous gray-brown mass infiltrating the bronchial
wall and penetrating from the direction of the bronchus of
the lower lobe (Figure 6). To increase the bronchial lumen
and improve the drainage, small parts of the tumor were re-
moved. This intervention was repeated after 2 weeks, be-
cause the patient reported an improvement ofher condition.
Histologically, the tumor is rich in cells and already has
reached the surface ofthe bronchial mucosa. The tumor cells
form solid groups, are medium-size with partly pale,
eosinophilic cytoplasm, and contain numerous, focally lo-
calized, finely distributed, brownish, melaninlike pigment
granules. The cell nuclei are hyperchromic and are ovoid or
elongated, and some contain large nucleoli. There is an exo
pressedcellularatypiaandpolymorphism.Thebrownishpig-
ment tested positive for Grimelius and Masson-Fontana
silver stainings, and the immunohistochemical HMB-45
melanomaresultwasalsopositive. All these results supported
the diagnosis ofmelanoma malignum.
The biopsy material also was analyzed electromicro-
scopically; the cells containing the brownish melaninlike
pigment also displayed numerous premelanosomes or
melanosomes of high electron density (Figures 7 and 8).
The patient was observed for 4 months and was hospi-
talized for 23 days from this period. The analyses performed
could not reveal the presence of malignant melanoma ex-
cept in the bronchopulmonary location. The careful derma-CLINICAL SIGNIFICANCE OF THE PRIMARY MALIGNANT MELANOMA 173
Figure 5 Chest X-ray ofpa and tomographic image of left lateral direction. An egg-sized shadow in the region of S-10 and lymphnode masses in the hilus.
toIogic analyses remained negative formelanoma, therefore
no skin biopsy was performed. Otorhinolaryngologic,
oculistic, neurologic, and gynecologic, and abdominal ul-
trasound examinations were negative.
When the patient died from respiratory and circulatory
insufficiency, autopsy could not be performed because
family consent was not available.
DISCUSSION
The first authentic primary malignant bronchopulmonal
melanoma was described by Salm in 1963. In some of the
cases described in later publications, one has to doubt the
primary lung and/or bronchial origin. (22-26). The most
serious issue is the exclusion of the metastatic origin of
the tumor, because according to some opinions, skin
melanomas may spontaneously disappear without any
trace after they already have metastased. (2,27). However
even if one accepts the possibility of the eventual, rare
spontaneous regression of the primary skin melanoma,
Figure 7 Melanoblastic proliferative mass infiltrating the bronchial
wall x 65, hematoxylin-eosin staining.
Figure 6 A tumor considerably closing the lumen of the main left
bronchus, deriving from the bronchus of the lower lobe.
Figure 8 Electron micrograph showing numerous premelanosomes
and melanosomes of high electron density in the tumor cells. Primary
magnification: x 4000.174 P. BARZO et al.
one should generally expect a later generalization (27). It
is also a fact that more than 15% of the metastatic
melanomas have a hidden primary tumor (28). Therefore
Jensen and Egedorf already have defined in 1967 the
mainly clinical conditions necessary for the safe diagno-
sis of the primary malignant melanoma of the lower res-
piratory tract. These conditions include:
1. No previous removal of pigmented skin tumor or
any kind of skin tumor
2. No removal of eye tumors, especially through enu-
cleation
3. Surgically removed specimen with a solitary tumor
4. Morphology of tumor corresponds to the primary
origin
5. No detectable melanoma in any other organ at time
of surgical intervention
6. No primary malignant melanoma found, especially
in the skin and the eyes, at autopsy.
The macroscopic and histologic properties ofthe tumor
may offer furtherevidence for the origin ofthe tumorfrom
the lower respiratory tract (6,15,21,29). Primary process
is likely, if the tumor is polypoid and localized intralumi-
nally, whereas the metastases are usually disseminated.
The histologic conditions include:
1. Junctional alterations with the nestlike location or
"dropping" of the melanoma cells
2. Invasion ofmelanoma cells in the bronchial epithe-
lium at non-eroded places
3. Intraepithelial alterations that correspond unani-
mously to melanoma.
An accessory sign is considered to be the presence of
naevuslike alteration in the bronchial epithelium nearby
to the tumor and the melanoma flare that somewhat more
distantfrom the tumor. (6,15,21). In our firstreported case,
the listed histologic criteria were present, whereas in our
second case, not all criteria could be met, mainly because
of the small size of the bioptic materials.
Generally speaking, the above criteria are considered
valid, although the autopsy cannot always be performed,
as described in some published cases, because of long
postoperative survival orotherreasons. On the otherhand,
autopsy itself has some limitations especially in answer-
ing the dilemma of primary tumor or metastasis.
Therefore, ifthe obduction cannot be performed, the neg-
ative outcome of an extensive search for primary tumor
in vivo can be accepted. Using modem endoscopic and
imaging procedures, the probability of error can be re-
duced. Therefore, although the criteria definedby Jensen-
Egedorf(1967) for the diagnosis ofthe primary malignant
melanoma of the lower respiratory tract should be con-
sidered the standard, cases should be qualified based on
the analysis of all test results and on common sense.
In both ourcases,wefound a solitary tumorwith metas-
tases in the hilus of the identical side. The malignant
melanoma was proved by histologic, histochemic, and
electronmicroscopic techniques. The tumors didnotshow
any morphologic signs that suggested their metastatic
ongn.
According to the data (see Table 1), the primary malig-
nantmelanoma ofthe lower respiratory tract and/or lung in-
volves both sexes almost equally. At time of diagnosis, the
youngest patient was 33, the oldest 81 years of age. Of the
14 operated cases (lobectomy andpulmonectomy), two and
onepatients,respectively, are still alive, i.e., after3 to4years,
and one patient in each group survived after 10 to 11 years.
Three patients were alive 2 to 30 months after the interven-
tion. Five patients died between 5.5 and 22 months, and one
patient died during the postoperative phase of tracheal re-
section. There was one patient who underwent successful
fight lower lobectomy the whose survival is not known.
The tumor was endobronchial in seven patients, and
was intratracheal in one patient. The endobronchial loca-
tion was accompanied by the involvement of the adjacent
lung area in two persons, and exclusive parenchymal lo-
cation was seen in eight cases. These facts indicate the
significance of the bronchoscopy in the diagnosis.
Operability and Survival are determined not by the
bronchial or parenchymal location but by extension and
circumscription of the tumor. The presence of a solitary,
metastatic hilar lymph node, even if it is of considerable
size, does not predict an unequivocal bad prognosis, as
was shown in our first case.
In the therapy ofthe primary malignantmelanomaofthe
lower respiratory tract, surgical removal is most important;
considerable survival can be expected only from this in-
tervention. The cytostatic treatments applied so far in the
inoperable cases did not give any result; the effects of the
adjuvant treatments cannot be measured either. Therefore,
the main task is to detect the tumor as early as possible and
if operable, surgical intervention must be performed.
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